Allergan reported to seek other partners

Share this article:

Bloomberg reports that Allergan has pursued Sanofi and Johnson & Johnson to partner up and help the company avoid being absorbed by Valeant.

Valeant's $45.7-billion bid is its second offer, and one which Bloomberg noted that Allergan has not yet responded to. According to the news service, it's not clear if Sanofi or J&J have said they are interested in the Botox maker.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.